|
Cone beam CT enhanced scan in evaluating the efficacy and prognosis of interventional chemoembolization and radiation for liver cancer
|
S. Zhao   , L. Wang , J. Xia , L. Liu |
| Operating Room, Shaoxing People's Hospital, Shaoxing 312000, Zhejiang Province, China |
|
|
Abstract: (728 Views) |
Background: This work analyzed the efficacy of Cone-Beam Computed Tomography (CBCT) enhanced scan in evaluating the therapeutic effect and prognosis of interventional therapy in patients with liver cancer (LC). Materials and Methods: Eighty-two individuals diagnosed with primary LC were enrolled here and grouped according to the intraoperative treatment. Patients in group A were only treated with digital subtraction angiography (DSA) during the operation, while those in group B received DSA and CBCT during the operation. The operation time, radiation dose, detection rate of tumor lesions, and lipiodol deposition were compared between two groups. Results: In group A, 54 lesions were identified before operation, 48 lesions during intraoperative angiography, and 6 lesions remained undetected. In group B, 57 LC lesions were identified before operation, and 57 lesions during intraoperative CBCT enhanced scan, and 2 small LC lesions not presented previously were detected. The number of lesions with complete lipiodol precipitation in group B (42) was clearly higher as against group A (32) (P < 0.05). The operation time of group B was clearly longer as against group A (P < 0.05), but there existed no substantial difference in radiation dose patients in different groups (P > 0.05). Conclusion: The results indicated that CBCT enhanced scan was superior to conventional DSA in detecting tumor lesions, nutrient arteries, and lipiodol deposition in patients undergoing LC chemoembolization. Importantly, this enhanced method did not increase radiation dose but prolonged the operation time. |
|
| Keywords: Cone-beam computed tomography, hepatocellular carcinomas, transcatheter arterial chemoembolization, prognosis. |
|
|
Full-Text [PDF 601 kb]
(203 Downloads)
|
|
Type of Study: Original Research |
Subject:
Radiation Biology
|
|
|
|
|
|
|
| References |
|
1. Singh S, Chaurasia A, Gopal N, Malayeri A, Ball MW (2022) Treatment strategies for hereditary kidney cancer: Current recommendations and updates. Discov Med, 34(173): 205-220. PMID: 36602871. 2. Li CX, Chen B, Yu H, Zhang YG (2023) LncRNA DNM3OS Promotes tumorigenesis of liver cancer by inducing FOXO3a methylation via interacting with DNMT1. Journal of Biological Regulators and Homeostatic Agents, 37(1): 111-120. 3. Feng W, Wang Q, Wang S, Chen Z, Lin B (2022) Effect of indocyanine green (icg)-mediated near-infrared light guided liver tumor resection on the prognosis of patients with primary liver cancer. Acta Medica Mediterranea, 38: 4061. 4. Zhu, R, Du T, Gao H (2020) Effects of dezocine and ropivacaine infiltration anesthesia on cellular immune function indicators, anesthesia recovery time and pain factors in patients with open liver resection. Cellular and Molecular Biology, 66(3): 149-154. [ DOI:10.14715/cmb/2020.66.3.23] 5. Marengo A, Rosso C, Bugianesi E (2016) Liver cancer: Connections with obesity, fatty liver and cirrhosis. Annu Rev Med, 67: 103-117. [ DOI:10.1146/annurev-med-090514-013832] [ PMID] 6. Anwanwan D, Singh SK, Singh S, Saikam V, Singh R (2020) Challenges in liver cancer and possible treatment approaches. Biochim Biophys Acta Rev Cancer, 1873(1): 188314. [ DOI:10.1016/j.bbcan.2019.188314] [ PMID] [ ] 7. Li X, Ramadori P, Pfister D, Seehawer M, Zender L, Heikenwalder M (2021) The immunological and metabolic landscape in primary and metastatic liver cancer. Nat Rev Cancer, 21(9): 541-557. doi: 10.1038/s41568-021-00383-9. Epub 2021 Jul 29. PMID: 34326518. [ DOI:10.1038/s41568-021-00383-9] [ PMID] 8. Zheng Y, Wang S, Cai J, Ke A, Fan J (2021) The progress of immune checkpoint therapy in primary liver cancer. Biochim Biophys Acta Rev Cancer, 1876(2): 188638. doi: 10.1016/j.bbcan.2021.188638. Epub 2021 Oct 22. PMID: 34688805. [ DOI:10.1016/j.bbcan.2021.188638] [ PMID] 9. Bhardwaj H, Tomar P, Sakalle A, Bhardwaj A, Asthana R, Vidyarthi A (2023) EEG based personality prediction using genetic programming. Wiley, 2023: 1-13. [ DOI:10.1002/asjc.3019] 10. Gao S, Gang J, Yu M, Xin G, Tan H (2021) Computational analysis for identification of early diagnostic biomarkers and prognostic biomarkers of liver cancer based on GEO and TCGA databases and studies on pathways and biological functions affecting the survival time of liver cancer. BMC Cancer, 21(1): 791. doi: 10.1186/s12885-021-08520-1. PMID: 34238253; PMCID: PMC8268589. [ DOI:10.1186/s12885-021-08520-1] [ PMID] [ ] 11. Huang J, Wang L, Siddik A B, Abdul-Samad Z, Bhardwaj A, Singh B (2023) Forecasting GHG emissions for environmental protection with energy consumption reduction from renewable sources: A sustainable environmental system. Ecological Modelling, 475: 110181. [ DOI:10.1016/j.ecolmodel.2022.110181] 12. Shiani A, Narayanan S, Pena L, Friedman M (2017) The Role of Diagnosis and Treatment of Underlying Liver Disease for the Prognosis of Primary Liver Cancer. Cancer Control, 24(3): 1073274817729240. doi: 10.1177/1073274817729240. PMID: 28975833; PMCID: PMC5937237. [ DOI:10.1177/1073274817729240] [ PMID] [ ] 13. Wege H, Schulze K, von Felden J, Calderaro J, Reig M (2021) Rare liver tumors working group of the European Reference Network on Hepatological Diseases (ERN RARE-LIVER). Rare variants of primary liver cancer: Fibrolamellar, combined, and sarcomatoid hepatocellular carcinomas. Eur J Med Genet, 64(11): 104313. doi: 10.1016/j.ejmg.2021.104313. Epub 2021 Aug 18. PMID: 34418585. [ DOI:10.1016/j.ejmg.2021.104313] [ PMID] 14. Gao YX, Yang TW, Yin JM, Yang PX, Kou BX, Chai MY, et al. (2020) Progress and prospects of biomarkers in primary liver cancer (Review). Int J Oncol, 57(1): 54-66. doi: 10.3892/ijo.2020.5035. Epub 2020 Apr 1. PMID: 32236573. [ DOI:10.3892/ijo.2020.5035] 15. Wang J, Liu X, Jin T, Cao Y, Tian Y, Xu F (2022) NK cell immunometabolism as target for liver cancer therapy. Int Immunopharmacol, 112: 109193. doi: 10.1016/j.intimp.2022.109193. Epub 2022 Sep 7. PMID: 36087507. [ DOI:10.1016/j.intimp.2022.109193] [ PMID] 16. Krishan A and Mittal D (2021) Ensembled liver cancer detection and classification using CT images. Proc Inst Mech Eng H, 235(2): 232-244. doi: 10.1177/0954411920971888. Epub 2020 Nov 13. PMID: 33183141. [ DOI:10.1177/0954411920971888] [ PMID] 17. Rahimi A, Khalil A, Faisal A, Lai KW (2022) CT-MRI Dual Information Registration for the Diagnosis of Liver Cancer: A Pilot Study Using Point-based Registration. Curr Med Imaging, 18(1): 61-66. doi: 10.2174/1573405617666210825155659. PMID: 34433403. [ DOI:10.2174/1573405617666210825155659] [ PMID] 18. Kumar A, Sinha N, Bhardwaj A, Goel S (2022) Clinical risk assessment of chronic kidney disease patients using genetic programming. Computer Methods in Biomechanics and Biomedical Engineering, 25(8): 887-895. [ DOI:10.1080/10255842.2021.1985476] [ PMID] 19. Ayuso C, Rimola J, Vilana R, Burrel M, Darnell A, García-Criado Á, et al. (2018) Diagnosis and staging of hepatocellular carcinoma (HCC): current guidelines. Eur J Radiol, 101: 72-81. doi: 10.1016/j.ejrad.2018.01.025. Epub 2018 Jan 31. Erratum in: Eur J Radiol. 2019 Mar; 112:229. PMID: 29571804. [ DOI:10.1016/j.ejrad.2018.01.025] [ PMID] 20. Feng YS, Zhou JM, Sun CH, Zhu J, Yang J, Guo L (2021) The diagnostic value of miR-21 combined with CT in patients with liver cancer. Clin Transl Oncol, 23(6): 1238-1244. doi: 10.1007/s12094-020-02514-4. Epub 2020 Nov 18. PMID: 33206331. [ DOI:10.1007/s12094-020-02514-4] [ PMID] 21. Luz JHM, Veloso Gomes F, Costa NV, Vasco I, Coimbra E, Luz PM, et al. (2021) BestFLR Trial: Liver Regeneration at CT before Major Hepatectomies for Liver Cancer-A Randomized Controlled Trial Comparing Portal Vein Embolization with N-Butyl-Cyanoacrylate Plus Iodized Oil versus Polyvinyl Alcohol Particles Plus Coils. Radiology, 299(3): 715-724. doi: 10.1148/radiol.2021204055. Epub 2021 Apr 6. PMID: 33825512. [ DOI:10.1148/radiol.2021204055] [ PMID] 22. Turukmane AV, Alhebaishi N, Alshareef AM, Mirza OM, Bhardwaj A, Singh B (2022) Multispectral image analysis for monitoring by IoT based wireless communication using secure locations protocol and classification by deep learning techniques. Optik, 271: 170122 [ DOI:10.1016/j.ijleo.2022.170122] 23. Ebadi N, Li R, Das A, Roy A, Nikos P, Najafirad P (2023) CBCT-guided adaptive radiotherapy using self-supervised sequential domain adaptation with uncertainty estimation. Med Image Anal, 86: 102800. doi: 10.1016/j.media.2023.102800. Epub 2023 Mar 16. PMID: 37003101. [ DOI:10.1016/j.media.2023.102800] [ PMID] 24. Stefanelli A, Sabourin V, Hines K, Matias C, Acharya S, Sharan A, et al. (2022) Digital subtraction angiography may reduce the rate of radiographic hemorrhage in stereoelectroencephalography. World Neurosurg, 164: e964-e969. doi: 10.1016/j.wneu.2022.05.081. Epub 2022 May 25. PMID: 35643404. [ DOI:10.1016/j.wneu.2022.05.081] [ PMID] 25. Kato N, Yuki I, Otani K, Ishibashi T, Kakizaki S, Nagayama G, et al. (2021) Flow diverter apposition in patients with large or giant intracranial aneurysms evaluated on three-dimensional fusion images acquired by high-resolution cone-beam computed tomography and digital subtraction angiography. World Neurosurg, 147: e388-e395. doi: 10.1016/j.wneu.2020.12.068. Epub 2021 Jan 7. PMID: 33359518. [ DOI:10.1016/j.wneu.2020.12.068] [ PMID] 26. Kong Y, Jing Y, Sun H, Zhou S (2022) The diagnostic value of contrast-enhanced ultrasound and enhanced ct combined with tumor markers afp and ca199 in liver cancer. J Healthc Eng, 2022: 5074571. doi: 10.1155/2022/5074571. PMID: 35237392; PMCID: PMC8885265. [ DOI:10.1155/2022/5074571] [ PMID] [ ] 27. Liu MY, Rose SC, Loh A, Taddonio M, Redmond JW, Meisinger QC, et al. (2022) Utility of cone-beam ct for bronchial artery embolization and chemoinfusion: a single-institution retrospective case series. Cardiovasc Intervent Radiol, 45(6): 834-840. doi: 10.1007/s00270-022-03148-5. Epub 2022 Apr 19. PMID: 35441243; PMCID: PMC9117382. [ DOI:10.1007/s00270-022-03148-5] [ PMID] [ ] 28. Su Y, Liu S, Guan Y, Xie Z, Zheng M, Jing X (2020) Renal clearable Hafnium-doped carbon dots for CT/Fluorescence imaging of orthotopic liver cancer. Biomaterials, 255: 120110. doi: 10.1016/j.biomaterials.2020.120110. Epub 2020 Jun 8. PMID: 32540755. [ DOI:10.1016/j.biomaterials.2020.120110] [ PMID] 29. Zhu H, Wang DD, Yuan T, Yan FJ, Zeng CM, Dai XY, et al. (2018) Multikinase inhibitor CT-707 targets liver cancer by interrupting the hypoxia-activated IGF-1R-YAP axis. Cancer Res, 78(14): 3995-4006. doi: 10.1158/0008-5472.CAN-17-1548. Epub 2018 Apr 18. PMID: 29669759. [ DOI:10.1158/0008-5472.CAN-17-1548] [ PMID] 30. Xu R, Wang J, Huang X, Zhang Q, Xie Y, Pang L, et al. (2019) Clinical value of spectral CT imaging combined with AFP in identifying liver cancer and hepatic focal nodular hyperplasia. J BUON, 24(4): 1429-1434. PMID: 31646787.
|
|
| Add your comments about this article |
|
|
|
|
Zhao S, Wang L, Xia J, Liu L. Cone beam CT enhanced scan in evaluating the efficacy and prognosis of interventional chemoembolization and radiation for liver cancer. Int J Radiat Res 2024; 22 (4) :1037-1042 URL: http://ijrr.com/article-1-5802-en.html
|
